FDA product code PCH: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System

PCH is the FDA product code for gastrointestinal pathogen panel multiplex nucleic acid-based assay system. It is a Class II device, regulated under 21 CFR 866.3990 and reviewed by the Microbiology panel. FDA has cleared 38 510(k) submissions under PCH, 17 in the last five years, from 16 different applicants. The average 510(k) review took 154 days (median 116); 211 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 24 recalls for PCH devices, 13 initiated in the last five years.

Definition

A gastrointestinal pathogen panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal microbial nucleic acids extracted from human stool specimens. The detection and identification of a specific gastrointestinal microbial nucleic acid from individuals exhibiting signs and/or symptoms of gastrointestinal infection aids in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation and other laboratory findings.

Classification

FieldValue
Device nameGastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
Device classClass II
Regulation21 CFR 866.3990
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

510(k) clearances per year for PCH

YearClearancesAvg. review days
2017190
20184126
20194184
20222205
2023129
20243411
2025767
20264154

Compare with all 510(k) review times · Search every PCH clearance

Top PCH applicants

ApplicantClearancesLatest
Luminex Molecular Diagnostics, Inc.72019-11-12
Biofire Diagnostics, LLC62026-11-06
QIAGEN GmbH52026-03-09
Becton, Dickinson and Company52022-09-21
Applied BioCode, Inc.32025-01-10

11 more applicants have PCH clearances. See the full list in Caduvo.

Most recent PCH clearances

510(k)ApplicantDeviceDecision dateReview days
K262172Biofire Diagnostics, LLCBIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel; BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel Mid2026-11-06133
K253722Luminex CorporationLIAISON PLEX Gastrointestinal Flex Assay2026-05-19176
K254032QIAGEN GmbHQIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B2026-03-0983
K251721CepheidXpert GI Panel2026-01-16226
K252329QIAGEN GmbHQIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B2025-10-2289

Recalls for PCH devices

24 product recalls in 17 recall events; 13 initiated in the last five years and 16 still open. Most recent: 2025-11-03.

YearRecalls
20181
20197
20212
20221
20235
20242
20255

Frequently asked questions

What is FDA product code PCH?

PCH is the FDA product code for gastrointestinal pathogen panel multiplex nucleic acid-based assay system. It is a Class II device, regulated under 21 CFR 866.3990 and reviewed by the Microbiology panel.

What device class is PCH?

Class II, regulation 21 CFR 866.3990. Typical premarket route: 510(k).

How long does a 510(k) take for product code PCH?

Across 38 cleared submissions the average was 154 days from receipt to decision (median 116).

Which companies have the most PCH clearances?

Luminex Molecular Diagnostics, Inc. (7); Biofire Diagnostics, LLC (6); QIAGEN GmbH (5); Becton, Dickinson and Company (5); Applied BioCode, Inc. (3).

Have PCH devices been recalled?

Yes: 24 product recalls across 17 recall events; the most recent began 2025-11-03.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times